Esophageal (Barrett's) adenocarcinoma is not associated with Epstein-Barr virus infection: An analysis of 162 cases [3]

International Journal of Cancer

Volumn 117, Issue 4, 2005, Pages 698-700

  Sarbia, Mario ^a,d   Zur Hausen, Axel ^b   Feith, Marcus ^a   Geddert, Helene ^c   Von Rahden, Burkhard H A ^a   Langer, Rupert ^a   Von Weyhern, Claus ^a   Siewert, J Rüdiger ^a   Höfler, Heinz ^a   Stein, Hubert J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CARDIA CARCINOMA; DEVICE; EPSTEIN BARR VIRUS; ESOPHAGEAL ADENOCARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; LETTER; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; VIRUS INFECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 27144518293     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21190     Document Type: Letter

References (16)

1. van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 2004;22:664-70.
2. Corvalan A, Koriyama C, Akiba S, Eizuru Y, Backhouse C, Palma M, Argandona J, Tokunaga M. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer 2001;94:527-30.
3. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
4. Wijnhoven BPL, Siersema PD, Hop WCJ, van Dekken H, Tilanus HW. Adenocarcinoma of the distal oesophagus and gastric cardia are one clinical entity. Br J Surg 1998;86:529-35.
5. Ectors N, Driessen A, De Hertog G, Lerut T, Geboes K. Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarcinoma? Arch Pathol Lab Med 2005;129:183-5.
6. Siewert JR, Stein H. Classification of adenocarcinoma of the esophago-gastric junction. Br J Cancer 1998;85:1457-9.
7. Sobin LH, Wittekind Ch, eds. UICC. TNM classification of malignant tumours, 6th ed. New York: John Wiley & Sons, 2002.
8. Just T, Burgwald H, Broe MK. Flow cytometric detection of EBV (EBER snRNA) using peptide nucleic acid probes. J Virol Methods 1998;73:163-74.
9. Fukayama M, Chong JM, Uozaki H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. Curr Top Microbiol Immunol 2001;258:91-102.
10. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res 2004;10:1698-705.
11. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang HP, Lin JT. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000;118:1031-8.
12. Association of directors of anatomic and surgical pathology: recommendations for the reporting of resected esophageal carcinomas. Virch Arch 2000;437:348-50.
13. Hamilton SR, Aaltonen LA, eds. World Health Organisation. Classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000.
14. Taniere P, Borghi-Scoazec G, Saurin JC, Lombard-Bohas C, Boulez J, Berger F, Hainaut P, Scoazec JY. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Path 2002;26:1213-21.
15. Taniere P, Martel-Planche G, Maurici D, Lombard-Bohas C, Scoazec JY, Montesano R, Berger F, Hainaut P. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol 2001;158:33-40.
16. ARF APC) in adenocarcinomas of the upper gastrointestinal tract. Int J Cancer 2004;111:224-8.